Giorgio De Bernardi

Giorgio De Bernardi's AcademicInfluence.com Rankings

Giorgio De Bernardi

Biology

#5542

World Rank

#8050

Historical Rank

Immunology

#268

World Rank

#279

Historical Rank

Neuroscience

#626

World Rank

#653

Historical Rank

biology Degrees

Download Badge

Biology

Giorgio De Bernardi's Degrees

PhD Immunology University of Milan
Masters Biotechnology University of Milan

Why Is Giorgio De Bernardi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giorgio De Bernardi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. (2007) (1153)
Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia (2003) (773)
Long-term synaptic depression in the striatum: physiological and pharmacological characterization (1992) (676)
Nigrostriatal Dopaminergic Deficits and Hypokinesia Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 (2005) (517)
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia (1996) (464)
Acetylcholine-mediated modulation of striatal function (2000) (438)
Mapping of motor cortical reorganization after stroke. A brain stimulation study with focal magnetic pulses. (1997) (417)
Re-emergence of striatal cholinergic interneurons in movement disorders (2007) (411)
Post‐ischemic brain damage: pathophysiology and role of inflammatory mediators (2009) (409)
Long‐term Potentiation in the Striatum is Unmasked by Removing the Voltage‐dependent Magnesium Block of NMDA Receptor Channels (1992) (404)
Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity (2000) (373)
Dopaminergic control of synaptic plasticity in the dorsal striatum (2001) (357)
Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. (1993) (319)
Inflammation Triggers Synaptic Alteration and Degeneration in Experimental Autoimmune Encephalomyelitis (2009) (317)
Experimental Parkinsonism Alters Endocannabinoid Degradation: Implications for Striatal Glutamatergic Transmission (2002) (310)
Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons (2001) (309)
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum (2008) (300)
Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors (1997) (294)
Synaptic transmission in the striatum: from plasticity to neurodegeneration (2000) (275)
Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: Evidence for D1 receptor involvement (1987) (267)
A Critical Interaction between NR2B and MAGUK in l-DOPA Induced Dyskinesia (2006) (263)
Presynaptic Facilitation of Glutamatergic Synapses to Dopaminergic Neurons of the Rat Substantia Nigra by Endogenous Stimulation of Vanilloid Receptors (2003) (254)
Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. (2004) (250)
Distinct Roles of D1 and D5 Dopamine Receptors in Motor Activity and Striatal Synaptic Plasticity (2003) (244)
SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis (2010) (235)
Receptor Subtypes Involved in the Presynaptic and Postsynaptic Actions of Dopamine on Striatal Interneurons (2003) (234)
Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. (2010) (230)
Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. (1997) (226)
A Critical Role of the Nitric Oxide/cGMP Pathway in Corticostriatal Long-Term Depression (1999) (222)
Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum (1992) (212)
Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors (2010) (211)
The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? (2005) (211)
Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones (1997) (209)
Properties of the Hyperpolarization‐activated Cation Current lh in Rat Midbrain Dopaminergic Neurons (1995) (206)
Abnormalities of short-latency somatosensory evoked potentials in parkinsonian patients. (1989) (206)
Gabapentin inhibits calcium currents in isolated rat brain neurons (1998) (205)
Unilateral dopamine denervation blocks corticostriatal LTP. (1999) (199)
'Excitability changes of muscular responses to magnetic brain stimulation in patients with central motor disorders. (1991) (195)
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. (2009) (187)
The endocannabinoid system in targeting inflammatory neurodegenerative diseases. (2007) (187)
Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. (1996) (187)
Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway (2009) (185)
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. (2007) (184)
Post-receptor mechanisms underlying striatal long-term depression (1994) (182)
Interleukin‐1β causes synaptic hyperexcitability in multiple sclerosis (2012) (182)
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory (2000) (175)
Dopamine excites fast-spiking interneurons in the striatum. (2002) (174)
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS (2003) (172)
The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis (2010) (170)
Electrophysiology of dopamine in normal and denervated striatal neurons (2000) (170)
Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease (2010) (166)
Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome (2008) (166)
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene (2001) (165)
Inhibition of Mitochondrial Complex II Induces a Long-Term Potentiation of NMDA-Mediated Synaptic Excitation in the Striatum Requiring Endogenous Dopamine (2001) (165)
Synaptic and intrinsic control of membrane excitability of neostriatal neurons. I. An in vivo analysis. (1990) (163)
N-Arachidonoyl-Dopamine Tunes Synaptic Transmission onto Dopaminergic Neurons by Activating both Cannabinoid and Vanilloid Receptors (2007) (161)
Activation of D2-Like Dopamine Receptors Reduces Synaptic Inputs to Striatal Cholinergic Interneurons (2000) (161)
Intracellular responses of caudate neurons to brain stem stimulation. (1970) (160)
The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction? (2003) (159)
Endogenous ACh enhances striatal NMDA‐responses via M1‐like muscarinic receptors and PKC activation (1998) (159)
Extracellular ATP and neurodegeneration. (2003) (159)
CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. (2003) (159)
Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones (1994) (156)
Sex-Hormone-Related Events in Migrainous Females. A Clinical Comparative Study Between Migraine With Aura and Migraine Without Aura (1995) (156)
Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment (1998) (155)
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases (2004) (153)
Levetiracetam does not modulate neuronal voltage-gated Na + and T-type Ca 2+ currents (2001) (153)
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients (2005) (153)
Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis (2007) (152)
Distinct Levels of Dopamine Denervation Differentially Alter Striatal Synaptic Plasticity and NMDA Receptor Subunit Composition (2010) (151)
Striatal synaptic plasticity: Implications for motor learning and Parkinson's disease (2005) (151)
Abnormal Ca2+-Calmodulin-Dependent Protein Kinase II Function Mediates Synaptic and Motor Deficits in Experimental Parkinsonism (2004) (151)
Synaptic plasticity in the ischaemic brain (2003) (145)
P2X7 Receptor Modulation on Microglial Cells and Reduction of Brain Infarct Caused by Middle Cerebral Artery Occlusion in Rat (2006) (144)
Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia (2006) (143)
Plasma Concentrations of Neuroactive Steroids before and after Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression (2002) (142)
Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. (2012) (141)
Differential Inhibition by Riluzole, Lamotrigine, and Phenytoin of Sodium and Calcium Currents in Cortical Neurons: Implications for Neuroprotective Strategies (1997) (141)
Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine (1982) (140)
A Critical Interaction between Dopamine D2 Receptors and Endocannabinoids Mediates the Effects of Cocaine on Striatal GABAergic Transmission (2004) (138)
Voltage‐Activated Calcium Channels: Targets of Antiepileptic Drug Therapy? (1997) (136)
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism (2003) (136)
FcγRIII discriminates between 2 subsets of Vγ9Vδ2 effector cells with different responses and activation pathways (2004) (135)
Subthalamic stimulation activates internal pallidus: Evidence from cGMP microdialysis in PD patients (2005) (134)
Activation of TRPV1 in the VTA Excites Dopaminergic Neurons and Increases Chemical- and Noxious-Induced Dopamine Release in the Nucleus Accumbens (2005) (134)
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: Implications for ischemia and Huntington's disease (1998) (132)
Inflammation Subverts Hippocampal Synaptic Plasticity in Experimental Multiple Sclerosis (2013) (132)
Endogenous Serotonin Excites Striatal Cholinergic Interneurons via the Activation of 5-HT 2C, 5-HT6, and 5-HT7 Serotonin Receptors: Implications for Extrapyramidal Side Effects of Serotonin Reuptake Inhibitors (2007) (131)
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia (2003) (130)
Intracellular responses of caudate neurons to temporally and spatially combined stimuli. (1973) (130)
Involvement of transient receptor potential‐like channels in responses to mGluR‐I activation in midbrain dopamine neurons (2003) (129)
Involvement of GABA systems in feedback regulation of glutamate‐and GABA‐mediated synaptic potentials in rat neostriatum. (1991) (128)
TRPV1 channels facilitate glutamate transmission in the striatum (2009) (127)
Intracellular Calcium Increase in Epileptiform Activity: Modulation by Levetiracetam and Lamotrigine (2004) (125)
Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients (2009) (125)
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP (1999) (125)
Dopamine, Acetylcholine and Nitric Oxide Systems Interact to Induce Corticostriatal Synaptic Plasticity (2003) (123)
Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? (2000) (122)
Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons (1998) (118)
Chronic Psychoemotional Stress Impairs Cannabinoid-Receptor-Mediated Control of GABA Transmission in the Striatum (2008) (118)
Activation of Group III Metabotropic Glutamate Receptors Depresses Glutamatergic Transmission at Corticostriatal Synapse (1997) (118)
Cellular factors controlling neuronal vulnerability in the brain (2000) (117)
The neostriatum beyond the motor function: experimental and clinical evidence. (1997) (117)
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease (2006) (117)
Cerebral plasticity after stroke as revealed by ipsilateral responses to magnetic stimulation. (1996) (116)
Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnoea syndrome (1998) (115)
Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation (2004) (111)
TNF-α-mediated anxiety in a mouse model of multiple sclerosis (2012) (111)
P2X2R purinergic receptor subunit mRNA and protein are expressed by all hypothalamic hypocretin/orexin neurons (2006) (111)
Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease (2008) (111)
Abnormal mGlu 5 Receptor/Endocannabinoid Coupling in Mice Lacking FMRP and BC1 RNA (2010) (109)
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation (2008) (108)
Selective involvement of mGlu1 receptors in corticostriatal LTD (2001) (108)
Identification and enrichment of spermatogonial stem cells displaying side‐population phenotype in immature mouse testis (2004) (107)
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis (2009) (107)
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations (2006) (107)
Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum (1997) (106)
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. (2008) (104)
Effect of Smoking on Cerebrovascular Reactivity (1996) (104)
Metabotropic Glutamate Receptors and Cell-Type-Specific Vulnerability in the Striatum: Implication for Ischemia and Huntington's Disease (1999) (103)
Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms (1985) (102)
Temperature sensitivity of dopaminergic neurons of the substantia nigra pars compacta: involvement of transient receptor potential channels. (2005) (101)
Multiple Mechanisms Underlying the Neuroprotective Effects of Antiepileptic Drugs Against In Vitro Ischemia (2006) (99)
Activation of quisqualate metabotropic receptors reduces glutamate and GABA-mediated synaptic potentials in the rat striatum (1992) (99)
Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells (2001) (98)
On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. (1995) (98)
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum (2004) (97)
Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis (2010) (97)
Carotid Artery Intima-Media Thickness and Lacunar Versus Nonlacunar Infarcts (2002) (96)
l-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease? (2011) (96)
Targeting striatal cholinergic interneurons in Parkinson’s disease: Focus on metabotropic glutamate receptors (2003) (96)
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons (1994) (96)
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis (2011) (93)
Permissive role of interneurons in corticostriatal synaptic plasticity (1999) (93)
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia (2010) (93)
Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis (2011) (92)
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity (2006) (92)
Chronic Haloperidol Promotes Corticostriatal Long-Term Potentiation by Targeting Dopamine D2L Receptors (2004) (92)
Cocaine and Amphetamine Depress Striatal GABAergic Synaptic Transmission through D2 Dopamine Receptors (2002) (90)
Immunolocalization of CB1 receptor in rat striatal neurons: A confocal microscopy study (2004) (90)
Lowered cAMP and cGMP signalling in the brain during levodopa‐induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms (2008) (90)
Muscarinic IPSPs in rat striatal cholinergic interneurones (1998) (89)
Loss of Muscarinic Autoreceptor Function Impairs Long-Term Depression But Not Long-Term Potentiation in the Striatum (2008) (89)
Voltage‐dependent membrane potential oscillations of rat striatal fast‐spiking interneurons (2003) (89)
Cognitive and Cortical Plasticity Deficits Correlate with Altered Amyloid-β CSF Levels in Multiple Sclerosis (2011) (89)
Glutamate-Triggered Events Inducing Corticostriatal Long-Term Depression (1999) (88)
L-Type Calcium Channels Mediate a Slow Excitatory Synaptic Transmission in Rat Midbrain Dopaminergic Neurons (1998) (88)
Hereditary spastic paraplegia: clinical genetic study of 15 families. (2004) (87)
Abnormal Sensitivity to Cannabinoid Receptor Stimulation Might Contribute to Altered Gamma-Aminobutyric Acid Transmission in the Striatum of R6/2 Huntington’s Disease Mice (2005) (87)
Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson’s disease (2006) (87)
Cholinergic Dysfunction Alters Synaptic Integration between Thalamostriatal and Corticostriatal Inputs in DYT1 Dystonia (2012) (87)
Activation of dopamine D1‐like receptors excites LTS interneurons of the striatum (2002) (86)
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System (2012) (86)
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. (2005) (86)
Dopamine D2 Receptor-Mediated Inhibition of Dopaminergic Neurons in Mice Lacking D2L Receptors (2002) (85)
Coactivation of GABAA and GABAB Receptor Results in Neuroprotection During In Vitro Ischemia (2004) (85)
Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneurons (2006) (83)
Transient receptor potential‐like channels mediate metabotropic glutamate receptor EPSCs in rat dopamine neurones (2004) (82)
Bilateral hemispheric activation in the early recovery of motor function after stroke. (1998) (82)
Vulnerability of Medium Spiny Striatal Neurons to Glutamate: Role of Na+/K+ ATPase (1995) (81)
Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia (2009) (81)
The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. (1992) (81)
Somatosensory evoked potentials during the ideation and execution of individual finger movements (1996) (81)
A Synaptic Mechanism Underlying the Behavioral Abnormalities Induced by Manganese Intoxication (2001) (81)
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility (2008) (80)
Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition (2010) (80)
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia (2004) (80)
The action of dopamine on rat caudate neurones intracellularly recorded (1978) (80)
Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission (1992) (79)
Endogenous Adenosine Mediates the Presynaptic Inhibition Induced by Aglycemia at Corticostriatal Synapses (1997) (79)
Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease (2013) (79)
Dopamine modulates CA1 hippocampal neurons by elevating the threshold for spike generation: An in vitro study (1984) (79)
Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study (2001) (79)
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. (2004) (79)
Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons. (1999) (79)
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum (2010) (78)
Neurophysiological evaluation of the central nervous impulse propagation in patients with sensorimotor disturbances. (1988) (78)
Distinguishing forms of generalized epilepsy using magnetic brain stimulation. (1996) (78)
Is pharmacological neuroprotection dependent on reduced glutamate release? (2000) (78)
The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons (2001) (78)
Cu/Zn-superoxide dismutase (GLY93→ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture (2004) (77)
PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington’s Disease (2015) (77)
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine (2009) (77)
Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons (2005) (77)
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment. (2002) (76)
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients (1999) (76)
Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons (2002) (75)
Pharmacologic reversal of cortical hyperexcitability in patients with ALS (2000) (75)
Opposite Membrane Potential Changes Induced by Glucose Deprivation in Striatal Spiny Neurons and in Large Aspiny Interneurons (1997) (75)
Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity (2011) (73)
Differential post‐translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid (2006) (73)
Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue (2001) (73)
Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington’s disease (2009) (73)
Visual alterations in de novo Parkinson's disease (1995) (73)
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis (2010) (72)
Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients (2013) (72)
Synaptic P2X7 and Oxygen/Glucose Deprivation in Organotypic Hippocampal Cultures (2004) (72)
Metabotropic Glutamate 2 Receptors Modulate Synaptic Inputs and Calcium Signals in Striatal Cholinergic Interneurons (2002) (72)
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons (1999) (71)
Endogenous dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum: Intracellular studies from naive and catecholamine-depleted rats (1988) (71)
Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis (2007) (71)
Inflammation inhibits GABA transmission in multiple sclerosis (2012) (71)
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability. (2002) (70)
Group I metabotropic glutamate receptors mediate an inward current in rat substantia nigra dopamine neurons that is independent from calcium mobilization. (1999) (70)
Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists (2001) (70)
Activation of metabotropic glutamate receptors induces an inward current in rat dopamine mesencephalic neurons (1993) (69)
Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease (2009) (69)
FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. (2004) (69)
Co‐localization of brain‐derived neurotrophic factor (BDNF) and wild‐type huntingtin in normal and quinolinic acid‐lesioned rat brain (2003) (68)
TRPV1 Channels Regulate Cortical Excitability in Humans (2012) (68)
Heterogeneity of Metabotropic Glutamate Receptors in the Striatum: Electrophysiological Evidence (1993) (68)
The Basal Ganglia III (1991) (68)
NR2B Subunit Exerts a Critical Role in Postischemic Synaptic Plasticity (2006) (68)
Down‐regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation (2004) (67)
The use of repetitive transcranial magnetic stimulation (rTMS) for the treatment of spasticity. (2009) (66)
Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo‐controlled study (2009) (66)
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis (2012) (66)
P2X3 receptor localizes into lipid rafts in neuronal cells (2004) (65)
The complex roles of neurosteroids in depression and anxiety disorders (2008) (65)
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients (2010) (64)
Blockade of M2‐like muscarinic receptors enhances long‐term potentiation at corticostriatal synapses (1998) (64)
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons (2001) (64)
Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery (2007) (63)
Brain excitability and long latency muscular arm responses: non-invasive evaluation in healthy and parkinsonian subjects. (1991) (63)
P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis. (2010) (63)
Increased neurosteroids synthesis after brain and spinal cord injury in rats (2000) (63)
Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss? (1998) (63)
The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson’s disease (2005) (62)
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis (2011) (62)
Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson’s disease (2003) (62)
Brain regional and cellular localization of gelatinase activity in rat that have undergone transient middle cerebral artery occlusion (2008) (61)
Parkinson's disease and somatosensory evoked potentials (1993) (61)
Metabotropic Glutamate Receptor 1 Mediates the Electrophysiological and Toxic Actions of the Cycad Derivative β-N-Methylamino-l-Alanine on Substantia Nigra Pars Compacta DAergic Neurons (2010) (61)
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis (2005) (61)
Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat. (2007) (60)
L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons. (1998) (60)
Glutamate Metabotropic Receptor Agonists Depress Excitatory and Inhibitory Transmission on Rat Mesencephalic Principal Neurons (1997) (60)
Bilateral simultaneous transcranial Doppler monitoring of flow velocity changes during visuospatial and verbal working memory tasks. (1996) (60)
Effect of Vigabatrin on motor responses to transcranial magnetic stimulation An effective tool to investigate in vivo GABAergic cortical inhibition in humans (2004) (58)
Synaptic and intrinsic control of membrane excitability of neostriatal neurons. II. An in vitro analysis. (1990) (58)
Improvement of hand dexterity following motor cortex rTMS in multiple sclerosis patients with cerebellar impairment (2008) (58)
Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons (2001) (58)
Brain-Derived Neurotrophic Factor Controls Cannabinoid CB1 Receptor Function in the Striatum (2010) (57)
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism (2005) (57)
Whole cell patch-clamp recordings of rat midbrain dopaminergic neurons isolate a sulphonylurea- and ATP-sensitive component of potassium currents activated by hypoxia. (1998) (57)
Altered cortico‐striatal synaptic plasticity and related behavioural impairments in reeler mice (2006) (57)
Multichannel visual evoked potentials in migraine. (1995) (57)
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity (2007) (57)
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans. (2011) (57)
Muscarinic receptors depress GABAergic synaptic transmission in rat midbrain dopamine neurons (2000) (57)
Action of GP 47779, the Active Metabolite of Oxcarbazepine, on the Corticostriatal System. I. Modulation of Corticostriatal Synaptic Transmission (1995) (57)
The action of acetylcholine and L-glutamic acid on rat caudate neurons (1976) (56)
Cathepsin D expression is decreased in Alzheimer's disease fibroblasts (2008) (55)
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis (2009) (55)
Evidence in favor of a neurotransmitter role of glycine in the rat cerebral cortex (1982) (55)
Actions of methylphenidate on dopaminergic neurons of the ventral midbrain (2005) (54)
Effects of anoxia on rat midbrain dopamine neurons. (1994) (54)
Responses of rat substantia nigra compacta neurones to L‐DOPA (1990) (54)
Nitric oxide inhibition aggravates ischemic damage of hippocampal but not of NADPH neurons in gerbils. (1994) (54)
Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration (2007) (54)
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease (2004) (54)
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na+/K+ ATPase (2006) (53)
Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial (2014) (53)
Estimation of cerebrovascular reactivity in migraine without aura. (1995) (53)
The mechanism of amphetamine‐induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro (1989) (53)
Intracellular studies on the action of L-glutamic acid on spinal neurones of the cat. (1972) (53)
A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia (2015) (53)
Tissue plasminogen activator is required for corticostriatal long‐term potentiation (2002) (52)
CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke (2004) (52)
Deep brain stimulation in Parkinson's disease patients: biochemical evidence. (2006) (51)
Migrainous stroke and the antiphospholipid antibodies. (1994) (51)
Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia. (2001) (51)
Transcranial magnetic stimulation of motor pathways directed to muscles supplied by cranial nerves in amyotrophic lateral sclerosis (2002) (51)
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis (2011) (51)
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia (2008) (51)
Curcumin Inhibits Activation of Vγ9Vδ2 T Cells by Phosphoantigens and Induces Apoptosis Involving Apoptosis-Inducing Factor and Large Scale DNA Fragmentation1 (2001) (50)
Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2 (2008) (50)
Inhibition of Persistent Sodium Current Fraction and Voltage‐gated L‐type Calcium Current by Propofol in Cortical Neurons: Implications for Its Antiepileptic Activity (2005) (50)
Endogenous GABA mediates presynaptic inhibition of spontaneous and evoked excitatory synaptic potentials in the rat neostriatum (1990) (50)
Extracellular ATP and nerve growth factor intensify hypoglycemia‐induced cell death in primary neurons: role of P2 and NGFRp75 receptors (2002) (50)
Stimulation of Nitric Oxide–cGMP Pathway Excites Striatal Cholinergic Interneurons via Protein Kinase G Activation (2001) (50)
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation. (1999) (50)
Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis (2011) (50)
Activation of Healthy Hemisphere in Poststroke Recovery: A Transcranial Doppler Study (1993) (49)
Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses. (1998) (49)
Inhibitory effects of trace amines on rat midbrain dopaminergic neurons (2004) (47)
Ipsilateral motor activation in patients with cerebral gliomas (1998) (47)
The Brain Cytoplasmic RNA BC1 Regulates Dopamine D2 Receptor-Mediated Transmission in the Striatum (2007) (47)
Molecular and synaptic changes in the hippocampus underlying superior spatial abilities in pre-symptomatic G93A+/+ mice overexpressing the human Cu/Zn superoxide dismutase (Gly93 → ALA) mutation (2006) (47)
Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study (1997) (47)
Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients (2011) (46)
Presynaptic muscarinic (M3) receptors reduce excitatory transmission in dopamine neurons of the rat mesencephalon (1999) (46)
Transcranial magnetic stimulation reveals an interhemispheric asymmetry of cortical inhibition in focal epilepsy (2000) (46)
Felbamate inhibits dihydropyridine-sensitive calcium channels in central neurons. (1996) (46)
Striatal modulation of cAMP‐response‐element‐binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease (2006) (46)
Influence of Sleep Deprivation on Neuroactive Steroids in Major Depression (2002) (46)
Effect of lamotrigine on EEG paroxysmal abnormalities and background activity: a computerized analysis. (1996) (46)
Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro. (2005) (46)
Ultrastructural study of nitric oxide synthase-containing striatal neurons and their relationship with parvalbumin-containing neurons in rats (1997) (45)
Activation of β1-Adrenoceptors Excites Striatal Cholinergic Interneurons through a cAMP-Dependent, Protein Kinase-Independent Pathway (2003) (45)
Group I metabotropic glutamate receptors activate burst firing in rat midbrain dopaminergic neurons (2002) (45)
Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases. (2010) (45)
Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease (2013) (45)
Nitrergic neurons make synapses on dual-input dendritic spines of neurons in the cerebral cortex and the striatum of the rat: implication for a postsynaptic action of nitric oxide (2000) (44)
Silver syndrome variant of hereditary spastic paraplegia (2008) (44)
Epileptiform discharge induced by 4-aminopyridine in magnesium-free medium in neocortical neurons: physiological and pharmacological characterization (1997) (44)
Experimental Parkinsonism Modulates Multiple Genes Involved in the Transduction of Dopaminergic Signals in the Striatum (2002) (44)
Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture (2010) (44)
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab (2013) (44)
Improvement of choreic movements by 1Hz repetitive transcranial magnetic stimulation in Huntington's disease patients (2005) (44)
Ethanol enhances GABAB‐mediated inhibitory postsynaptic transmission on rat midbrain dopaminergic neurons by facilitating GIRK currents (2009) (44)
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis (2012) (44)
Chronic Cocaine Prevents Depotentiation at Corticostriatal Synapses (2006) (44)
Lamotrigine Add‐On Therapy in Focal Epilepsy: Electroencephalographic and Neuropsychological Evaluation (1998) (43)
Lithium Treatment Blocks Long-Term Synaptic Depression in the Striatum (1993) (43)
Microdialysis in Parkinsonian Patient Basal Ganglia: Acute Apomorphine-Induced Clinical and Electrophysiological Effects Not Paralleled by Changes in the Release of Neuroactive Amino Acids (2001) (43)
Up-regulation of Glycohydrolases in Alzheimer's Disease Fibroblasts Correlates with Ras Activation* (2003) (43)
Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons (1998) (42)
Group III metabotropic glutamate receptor agonists modulate high voltage-activated Ca2+ currents in pyramidal neurons of the adult rat (1998) (42)
RNA interference as a tool for Alzheimer's disease therapy. (2007) (42)
Neurotensin induces an inward current in rat mesencephalic dopaminergic neurons (1993) (42)
Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease (2007) (42)
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors (2007) (42)
Group I mGluRs coupled to G proteins are regulated by tyrosine kinase in dopamine neurons of the rat midbrain. (2001) (42)
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance (2011) (42)
Quantitative EEG evaluation in normal elderly subjects during mental processes: age-related changes. (1994) (42)
l-dopa modulates motor cortex excitability in Alzheimer’s disease patients (2008) (41)
NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: Implications for Huntington's disease (2008) (41)
Transendothelial Migratory Pathways of Vδ1+TCRγδ+ and Vδ2+TCRγδ+ T Lymphocytes from Healthy Donors and Multiple Sclerosis Patients: Involvement of Phosphatidylinositol 3 Kinase and Calcium Calmodulin-Dependent Kinase II1 (2002) (41)
A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts (2004) (41)
Cerebrovascular Reactivity in Migraine With and Without Aura (1996) (40)
Short interval intracortical facilitation correlates with the degree of disability in multiple sclerosis (2013) (40)
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? insights from in vitro studies (2003) (40)
α-amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptors in spinal cord motor neurons are altered in transgenic mice overexpressing human Cu,Zn superoxide dismutase (Gly93→Ala) mutation (2003) (40)
A voltage-clamp analysis of NMDA-induced responses on dopaminergic neurons of the rat subtantia nigra zona compacta and ventral tegmental area (1992) (39)
Antiepileptic Drugs on Calcium Currents Recorded from Cortical and PAG Neurons: Therapeutic Implications for Migraine (2008) (39)
Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitus. (2011) (39)
Transmitter Release Associated with Long‐term Synaptic Depression in Rat Corticostriatal Slices (1995) (39)
Early treatment with high-dose interferon beta-1a reverses cognitive and cortical plasticity deﬁcits in multiple sclerosis. (2012) (39)
Risk of acute promyelocytic leukemia in multiple sclerosis (2011) (39)
The action of GABA on rat caudate neurones recorded intracellularly (1975) (39)
Aβ1–42 Detection in CSF of Alzheimer's disease is influenced by temperature: Indication of reversible Aβ1–42 aggregation? (2010) (39)
Reduced GABA Content in the Motor Thalamus during Effective Deep Brain Stimulation of the Subthalamic Nucleus (2011) (38)
Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson’s disease patients, but its action is related to modality and site of stimulation (2001) (38)
Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity (2009) (38)
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum. (2001) (38)
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the ‘indirect pathway’ (2002) (38)
Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection. (2009) (38)
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices (1996) (37)
Pattern visual evoked potentials and electroretinogram abnormalities in Parkinson's disease: Effects of L-dopa therapy (1989) (37)
Alpha1-adrenoceptor-mediated excitation of substantia nigra pars reticulata neurons (2000) (37)
Monoamine Oxidase Inhibition Causes a Long-Term Prolongation of the Dopamine-Induced Responses in Rat Midbrain Dopaminergic Cells (1997) (37)
Axotomy dependent purinergic and nitrergic co-expression (2004) (37)
Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia (2008) (37)
Neurosteroid and neurotransmitter alterations in Parkinson’s disease (2013) (37)
Removing pathogenic memories (2005) (37)
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum (2010) (36)
Intracellular sodium and calcium homeostasis during hypoxia in dopamine neurons of rat substantia nigra pars compacta. (1998) (36)
Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY93→ALA) mutation (2003) (36)
Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons (2007) (35)
Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: an electroencephalographic study (1995) (35)
Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy. (1998) (35)
Magnetic transcranial stimulation in healthy humans: influence on the behavior of upper limb motor units (1995) (35)
GABA depolarizes neurons in the rat striatum: An in vivo study (1991) (35)
Impaired Excitatory Transmission in the Striatum of Rats Chronically Intoxicated with Manganese (2001) (35)
Peripheral nerve extracellular matrix remodeling in Charcot-Marie-Tooth type I disease (2002) (35)
The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells (2005) (35)
Distinct mechanisms of presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta. (2005) (35)
Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor. (2004) (34)
The action of picrotoxin and bicuculline on rat caudate neurons inhibited by GABA (1976) (34)
Selective depression of synaptic transmission by tetanus toxin: A comparative study on hippocampal and neostriatal slices (1989) (34)
Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum (2013) (34)
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes (2004) (34)
Acanthocytosis as a predisposing factor for non-ketotic hyperglycaemia induced chorea-ballism (2005) (34)
Late-onset hereditary spastic paraplegia with thin corpus callosum caused by a new SPG3A mutation (2011) (34)
D2‐mediated modulation of N‐type calcium currents in rat globus pallidus neurons following dopamine denervation (2002) (34)
Distinct roles of group I mGlu receptors in striatal function (2008) (34)
Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions (2008) (34)
Psychopathological comorbidities in medication‐overuse headache: a multicentre clinical study (2016) (33)
Immunohistochemical localization of TRPC6 in the rat substantia nigra (2007) (33)
Electrical stimulation of mesencephalic cell groups (A9-A10) produces monosynaptic excitatory potentials in rat frontal cortex (1985) (33)
Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease (2012) (33)
Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones (2004) (32)
Distribution of TRPC1 receptors in dendrites of rat substantia nigra: a confocal and electron microscopy study (2006) (32)
Kainate‐induced currents in rat cortical neurons in culture are modulated by riluzole (2002) (32)
Hyperpolarization induces a rise in intracellular sodium concentration in dopamine cells of the substantia nigra pars compacta (1998) (32)
CSF tau levels influence cortical plasticity in Alzheimer's disease patients. (2011) (31)
Postsynaptic alteration of NR2A subunit and defective autophosphorylation of alphaCaMKII at threonine-286 contribute to abnormal plasticity and morphology of upper motor neurons in presymptomatic SOD1G93A mice, a murine model for amyotrophic lateral sclerosis. (2011) (31)
The blockade of K(+)-ATP channels has neuroprotective effects in an in vitro model of brain ischemia. (2007) (31)
Clinical and genetic study of a large SPG4 Italian family (2005) (31)
Characterization of human Enah gene. (2006) (31)
Modulation of gene expression following long-term synaptic depression in the striatum. (1999) (31)
Methylprednisolone treatment delays remote cell death after focal brain lesion (2008) (31)
Sensory (VEP, BAEP, SEP) and motor-evoked potentials, liquoral and magnetic resonance findings in multiple sclerosis. (1989) (31)
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis (2013) (31)
Role of Ca2+ in striatal LTD and LTP (1996) (31)
Clinical and genetic study of a large Italian family linked to SPG12 locus (2002) (30)
Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: The role of endogenous acetylcholine (2006) (30)
Trace Amines Depress GABAB Response in Dopaminergic Neurons by Inhibiting G-βγ-Gated Inwardly Rectifying Potassium Channels (2005) (30)
The load of amyloid-β oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients. (2012) (30)
Firing properties and functional connectivity of substantia nigra pars compacta neurones recorded with a multi‐electrode array in vitro (2010) (30)
Pharmacological identification of the K+ currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurones (2000) (30)
Differences in the neurotoxicity profile induced by ATP and ATPγS in cultured cerebellar granule neurons (2005) (29)
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis (2010) (29)
Endogenous Dopamine Amplifies Ischemic Long-Term Potentiation via D1 Receptors (2002) (29)
Cellular localization of TRPC5 in the substantia nigra of rat (2006) (29)
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis. (2007) (29)
SHORT COMUNICATIONEarly sodium elevations induced by combined oxygen and glucose deprivation in pyramidal cortical neurons (1998) (29)
Opioids decrease high-voltage activated calcium currents in acutely dissociated neostriatal neurons (1994) (29)
New locus for hereditary spastic paraplegia maps to chromosome 1p31.1‐1p21.1 (2005) (28)
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum (2006) (28)
Memantine Inhibits ATP-Dependent K+ Conductances in Dopamine Neurons of the Rat Substantia Nigra Pars Compacta (2007) (28)
The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory (2004) (28)
Learning discloses abnormal structural and functional plasticity at hippocampal synapses in the APP23 mouse model of Alzheimer's disease. (2010) (28)
Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism? (2014) (28)
Increasing doses of l-sulpiride reveal dose- and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogram (1995) (28)
Synaptic plasticity in the basal ganglia: A similar code for physiological and pathological conditions (2008) (28)
Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease (2008) (28)
Epilepsy‐induced abnormal striatal plasticity in Bassoon mutant mice (2009) (27)
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer’s disease patients (2012) (27)
Effects of Fluoxetine, Indomethacine and Placebo on 3α, 5α Tetrahydroprogesterone (THP) Plasma Levels in Uncomplicated Alcohol Withdrawal (2000) (27)
Spastic paraplegia, epilepsy, and mental retardation in several members of a family: a novel genetic disorder. (1993) (26)
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis (2010) (26)
Coordinate high-frequency pattern of stimulation and calcium levels control the induction of LTP in striatal cholinergic interneurons. (2004) (26)
Protective role of hydrogen peroxide in oxygen‐deprived dopaminergic neurones of the rat substantia nigra (2005) (26)
Acetyl-l-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism (2008) (26)
Kainic acid on neostriatal neurons intracellularly recorded in vitro: electrophysiological evidence for differential neuronal sensitivity (1990) (26)
The clinical efficacy of -DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus (2011) (26)
Dopaminergic and noradrenergic responses in the hippocampal slice preparation Evidence for different receptors (1984) (25)
Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease: clinical score and internal globus pallidus activity (2005) (25)
Effect of P2 purinoceptor antagonists on kainate-induced currents in rat cultured neurons (2000) (25)
Leukocyte Aggregation in Patients With a Previous Cerebral Ischemic Event (1994) (25)
Leukocyte Count and Aggregation during the Evolution of Cerebral Ischemic Injury (1998) (25)
An electrophysiological study of D2 dopaminergic actions in normal human retina: A tool in Parkinson's disease (1992) (25)
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study. (2005) (25)
Stimulus frequency, calcium levels and striatal synaptic plasticity (2003) (25)
Cell-type specificity of mGluR activation in striatal neuronal subtypes (2000) (25)
Neurophysiology of Parkinson's disease: from basic research to clinical correlates (1999) (24)
The modulation of calcium current by GABA metabotropic receptors in a sub‐population of pallidal neurons (1999) (24)
Transendothelial migratory pathways of V delta 1+TCR gamma delta+ and V delta 2+TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients: involvement of phosphatidylinositol 3 kinase and calcium calmodulin-dependent kinase II. (2002) (24)
Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease (2004) (24)
Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra (2003) (24)
Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage (2008) (24)
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis (2011) (23)
Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans (2009) (23)
Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy (2007) (23)
Trace amines depress D2‐autoreceptor‐mediated responses on midbrain dopaminergic cells (2010) (23)
Electrophysiological evidence for the presence of ionotropic and metabotropic excitatory amino acid receptors on dopaminergic neurons of the rat mesencephalon: an in vitro study. (1992) (23)
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation (2013) (23)
Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies. (2006) (23)
Changes in the expression of extracellular regulated kinase (ERK 1/2) in the R6/2 mouse model of Huntington's disease after phosphodiesterase IV inhibition (2012) (23)
Group I mGluRs modulate calcium currents in rat GP: Functional implications (1998) (23)
Extracellular adenosine triphosphate induces glutamate transporter‐1 expression in hippocampus (2007) (23)
Myofibrillar disruption in the rabbit soleus muscle after one‐week hindlimb suspension (1991) (22)
ALTERED ANANDAMIDE DEGRADATION IN ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (2009) (22)
Loss of striatal cannabinoid CB1 receptor function in attention‐deficit / hyperactivity disorder mice with point‐mutation of the dopamine transporter (2011) (22)
Hypoglycemia enhances ionotropic but reduces metabotropic glutamate responses in substantia nigra dopaminergic neurons. (2001) (22)
The weaver Mutation Reverses the Function of Dopamine and GABA in Mouse Dopaminergic Neurons (2000) (22)
Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine‐related drugs on rat midbrain dopaminergic neurons (1999) (21)
Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot–Marie–Tooth disease type 1A (2006) (21)
Responses of rat mesencephalic dopaminergic neurons to a prolonged period of oxygen deprivation (1994) (21)
Migraine-like disorder segregating with mtDNA 14484 Leber hereditary optic neuropathy mutation (2003) (21)
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients. (2014) (21)
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum (2008) (21)
Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-activated (HVA) calcium channels in dissociated neurones of rat cortex (2001) (21)
Novel SPG6 mutation p.A100T in a Japanese family with autosomal dominant form of hereditary spastic paraplegia (2006) (21)
Neuroprotective effects of riluzole: An electrophysiological and histological analysis in an in vitro model of ischemia (1999) (21)
Chemical modulation of synaptic transmission in the striatum. (1993) (20)
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons. (1999) (20)
An electrophysiological analysis of the protective effects of felbamate, lamotrigine, and lidocaine on the functional recovery from in vitro ischemia in rat neocortical slices (1998) (20)
Action mechanisms of γ-aminobutyric acid (GABA) and glycine on rat cortical neurons (1980) (20)
Hypoglycemia, Hypoxia, and Ischemia in a Corticostriatal Slice Preparation: Electrophysiologic Changes and Ascorbyl Radical Formation (1998) (20)
Association study of the 5-hydroxytryptamine6 receptor gene in Alzheimer's disease (2002) (20)
Differential patterns of interhemispheric functional disconnection in mild and advanced multiple sclerosis (2010) (20)
On the Effects of Psychostimulants, Antidepressants, and the Antiparkinsonian Drug Levodopa on Dopamine Neurons (2006) (20)
Leucocyte aggregation in acute cerebrovascular disease (1992) (20)
Subclinical autonomic dysfunction in spinobulbar muscular atrophy (Kennedy disease) (2011) (20)
Muscle phosphofructokinase deficiency (1997) (20)
Voltage‐activated sodium currents in a cell line expressing a Cu,Zn superoxide dismutase typical of familial ALS (1998) (20)
Cerebellar control of cortico-striatal LTD. (2008) (20)
Caffeine drinking potentiates cannabinoid transmission in the striatum: Interaction with stress effects (2009) (20)
Increased expression of the beta3 subunit of voltage-gated Na+ channels in the spinal cord of the SOD1G93A mouse (2011) (20)
Effects of glycine on neurons in the rat substantia nigra zona compacta: In vitro electrophysiological study (1990) (19)
A Possible Mechanism for the Aglycemia-Induced Depression of Glutamatergic Excitation in the Striatum (1997) (19)
Increase of dopamine β-hydroxylase immunoreactivity in non-noradrenergic nerves of rat cerebral arteries following long-term sympathectomy (1991) (19)
Quantitative EEG changes in non‐demented Parkinson's disease patients before and during L‐dopa therapy (1996) (19)
Depression of mGluR‐mediated IPSCs by 5‐HT in dopamine neurons of the rat substantia nigra pars compacta (2003) (19)
Effect of carbamazepine on EEG background activity and on interictal epileptiform abnormalities in focal epilepsy. (1993) (19)
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study (2003) (19)
Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b (2005) (19)
Depletion of catecholamines reveals inhibitory effects of bromocryptine and lysuride on neostriatal neurones recorded intracellularly in vitro (1988) (19)
Hypoxia-Induced Electrical Changes in Striatal Neurons (1995) (19)
The inhibitory action of glycine on rat cortical neurons (1979) (19)
Transcranial Doppler assessment of the functional effects of symptomatic carotid stenosis (1994) (19)
Leukocyte and platelet aggregation in patients with ischemic stroke: a case-control study. (1993) (19)
On the inhibition of voltage activated calcium currents in rat cortical neurones by the neuroprotective agent 619C89 (1998) (18)
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus (2005) (18)
The action of glycine on rat epileptic foci (1981) (18)
Plasmin system of Alzheimer’s disease patients: CSF analysis (2012) (18)
Glutamate receptor stimulation induces a persistent rhythmicity of the GABAergic inputs to rat midbrain dopaminergic neurons (2001) (18)
l-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases (2006) (18)
NADPH-Diaphorase Neurons Contacting the Cerebrospinal Fluid in the Ventricles of Rat Brain (1996) (18)
Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin (2010) (18)
A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro (2012) (17)
Induction of corticostriatal LTP by 3-nitropropionic acid requires the activation of mGluR1/PKC pathway (2004) (17)
Dopamine selectively reduces GABAB transmission onto dopaminergic neurones by an unconventional presynaptic action (2002) (17)
Curcumin inhibits activation of Vgamma9Vdelta2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. (2001) (17)
Lateralization of the epileptogenic focus by computerized EEG study and neuropsychological evaluation. (1992) (17)
Nomifensine but not amantadine increases dopamine-induced responses on rat substantia nigra zona compacta neurons (1991) (17)
Electrophysiological and Clinical Desensitization to Apomorphine Administration in Parkinsonian Patients Undergoing Stereotaxic Neurosurgery (1999) (17)
Temporal lobe epileptic activity mimicking dementia: a case report (2005) (17)
Electrophysiological effects of monoamine oxidase inhibition on rat midbrain dopaminergic neurones: an in vitro study (1996) (16)
Partial block of glycolysis in late-onset phosphofructokinase deficiency myopathy (1996) (16)
1-Deprenyl Test in Migraine: Neuroendocrinological Aspects (1993) (16)
Altered vulnerability to kainate excitotoxicity of transgenic-Cu/Zn SOD1 neurones (2004) (16)
Huntingtin distribution among striatal output neurons of normal rat brain (2003) (16)
Hypoxia in striatal and cortical neurones: membrane potential and Ca2+ measurements (1997) (16)
Trace amines reduce GABAB receptor-mediated presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta (2005) (16)
Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons (2011) (16)
N-Methyl-d-aspartate receptors mediate a slow excitatory postsynaptic potential in the rat midbrain dopaminergic neurons (1996) (16)
Migraine with Aura-Like Syndrome Due to Arteriovenous Malformation. The Clinical Value of Transcranial Doppler in Early Diagnosis (1992) (16)
Antiparkinsonian and anti-levodopa-induced dyskinesia effects obtained by stimulating the same site within the GPi in PD (1998) (15)
Minocycline Attenuates Microglial Activation but Fails to Mitigate Degeneration in Inferior Olive and Pontine Nuclei After Focal Cerebellar Lesion (2008) (15)
Potassium ions play a role in the glycine-induced inhibition of rat substantia nigra zona compacta neurones (1988) (15)
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease (2006) (15)
Hippocampus versus entorhinal cortex decoupling by an NR2 subunit–specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy (2012) (15)
Functional and ultrastructural analysis of group I mGluR in striatal fast‐spiking interneurons (2007) (15)
Opioid‐mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: Focus on kappa response (2004) (15)
Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: a novel mutation in the SPG11 gene and further evidence for genetic heterogeneity (2009) (15)
The l-amino acid carrier inhibitor 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH) reduces l-dopa-elicited responses in dopaminergic neurons of the substantia nigra pars compacta (2008) (15)
A Case of PANDAS Treated With Tetrabenazine and Tonsillectomy (2010) (15)
Action of GABA on rat caudate neurones intracellularly recorded (1975) (15)
Electrophysiological pharmacology of the autoreceptor-mediated responses of dopaminergic cells to antiparkinsonian drugs. (1997) (15)
A-current in rat globus pallidus: A whole-cell voltage clamp study on acutely dissociated neurons (1992) (15)
Voltage-gated calcium channels mediate intracellular calcium increase in weaver dopaminergic neurons during stimulation of D2 and GABAB receptors. (2004) (15)
Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes (2000) (15)
Dopamine Decreases the Amplitude of Excitatory Post-Synaptic Potentials in Rat Striatal Neurones (1984) (15)
Delayed focal involvement of upper motor neurons in the Madras pattern of motor neuron disease. (1998) (15)
Impaired inter-hemispheric facilitatory connectivity in schizophrenia (2011) (15)
Dopamine-containing neurons are silenced by energy deprivation: a defensive response or beginning of cell death? (2005) (14)
Preliminary evidence for an association between aggressive and hostile behaviour and 3alpha,5alpha-tetrahydroprogesterone plasma levels in schizophrenia. (2005) (14)
Early subclinical cochlear dysfunction in myotonic dystrophy type 1 (2011) (14)
A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterations (1999) (14)
Haloperidol delays pattern electroretinograms more than visual evoked potentials in normal humans : a pharmacological tool in Parkinson's disease pathophysiology (1991) (14)
The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles (2010) (14)
The Impact of Rotigotine on Cardiovascular Autonomic Function in Early Parkinson’s Disease (2012) (14)
Sildenafil increases cerebrovascular reactivity: A transcranial Doppler study (2005) (14)
Differential distribution of nicotinamide adenine dinucleotide phosphate-diaphorase and neural nitric oxide synthase in the rat choroid plexus. A histochemical and immunocytochemical study (1996) (14)
GABAA receptor active steroids are altered in epilepsy patients with tuberous sclerosis (2003) (14)
Recovery cycle of visual evoked potentials in normal and schizophrenic subjects. (1967) (14)
Electrophysiological effects of amineptine on neurones of the rat substantia nigra pars compacta: evidence for an inhibition of the dopamine uptake system (1991) (13)
Na+/Ca2+ Exchanger Maintains Ionic Homeostasis in the Peri-Infarct Area (2007) (13)
Physiology and pharmacology of dopamine D2‐receptors (1989) (13)
Difficulty diagnosing chronic cryptococcal meningitis in idiopathic CD4+ lymphocytopenia (2011) (13)
Outward potassium currents activated by depolarization in rat globus pallidus (1995) (13)
Neurotensin effects on N‐type calcium currents among rat pallidal neurons: An electrophysiological and immunohistochemical study (2006) (13)
Acetylcholine-dopamine balance in striatum: is it still a target for antiparkinsonian therapy? (1989) (12)
Orbital Pseudotumor: Case Report and Literature Review (1999) (12)
Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms (2002) (12)
Spastic paraplegia in Romania: high prevalence of SPG4 mutations (2007) (12)
Immunocytochemical localization of vinculin in muscle and nerve (1995) (11)
Electrophysiology of Sipatrigine: A Lamotrigine Derivative Exhibiting Neuroprotective Effects (2000) (11)
Mechanisms of Disease: basic-research-driven investigations in humans—the case of hyperkinetic disorders (2007) (11)
Localization of ataxin-2 within the cerebellar cortex of the rat (2001) (11)
Cannabinoid CB 1 receptors regulate neuronal TNF-a effects in experimental autoimmune encephalomyelitis (2011) (11)
Role of dopamine receptors in the short- and long-term regulation of corticostriatal transmission. (1997) (11)
Muscle regeneration in mdx mice: Resistance to repeated necrosis is compatible with myofiber maturity (1997) (11)
Hashimoto's encephalopathy presenting with musical hallucinosis (2003) (11)
Dystrophin is not essential for the integrity of the cytoskeleton (1994) (10)
Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels. (2005) (10)
Epileptic activity following 10 minute cerebral ischemia in Mongolian gerbils: An electrophysiological study (1990) (10)
Engagement of rat striatal neurons by cortical epileptiform activity investigated with paired recordings. (2004) (10)
Dopamine uptake inhibition potentiates the effects of l-DOPA on rat substantia nigra zona compacta neurons (1991) (10)
Partial resistance of ataxin-2-containing olivary and pontine neurons to axotomy-induced degeneration (2005) (10)
The modulation of dopamine receptors in rat striatum. (1995) (10)
Tissue plasminogen activator is required for striatal post-ischemic synaptic potentiation (2002) (10)
SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status (1997) (10)
Adaptations of Striatal Endocannabinoid System During Stress (2009) (10)
Properties of dopaminergic neurons in organotypic mesencephalic–striatal co‐cultures – evidence for a facilitatory effect of dopamine on the glutamatergic input mediated by α‐1 adrenergic receptors (2011) (10)
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors. (2010) (10)
Characterization of a Barium‐sensitive Outward Current following Glutamate Application on Rat Midbrain Dopaminergic Cells (1996) (9)
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase (2002) (9)
Specific expression of galanin in the peri-infarct zone after permanent focal cerebral ischemia in the rat (2006) (9)
L‐AP4 inhibits high voltage‐activated Ca2+ currents in pyramidal cortical neurones (1996) (9)
Primary CNS demyelinating diseases in childhood: multiple sclerosis (1996) (9)
Postsynaptic Alteration of NR 2 A Subunit and Defective Autophosphorylation of alphaCaMKII at Threonine-286 Contribute to Abnormal Plasticity and Morphology of Upper Motor Neurons in Presymptomatic SOD 1 G 93 A Mice , a Murine Model for Amyotrophic Lateral Sclerosis (2011) (8)
Neuroactive Steroids in Responders and Nonresponders to Sleep Deprivation (2004) (8)
Morphological and functional study of dwarf neurons in the rat striatum (1998) (8)
Hypoxic and hypoglycaemic changes of intracellular pH in cerebral cortical pyramidal neurones (1998) (8)
NADPH diaphorase activity is inhibited by EDTA in neurons but not in choroid plexus epithelium (1993) (8)
The anorexic agents, sibutramine and fenfluramine, depress GABAB‐induced inhibitory postsynaptic potentials in rat mesencephalic dopaminergic cells (2009) (8)
Does the Antimigraine Action of Flunarizine Involve the Dopaminergic System? A Clinical-Neuroendocrinological Study (1999) (8)
Impairment of mitochondrial metabolism differentially affects striatal neuronal subtypes (2002) (8)
Deficits of glutamate transmission in the striatum of experimental hemiballism (2006) (8)
Research Actuality in the Genetics of Stroke (2006) (7)
Recovery cycle of visual evoked potentials in man. (1967) (7)
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein (2007) (7)
Localization of α-bungarotoxin binding sites within the rat corpus striatum (1979) (7)
Analysis of sympathetic skin responses in a group of healthy subjects and in patients affected by sphincter disorders and impotence. (1991) (7)
Sural nerve without nerve fibers in leprous neuropathy. (2002) (7)
The activation of μ opioid receptors promotes a small modulation of calcium currents in rat pallidal neurons (2001) (7)
Modification of levodopa responses by deprenyl (selegiline): An electrophysiological and behavioral study in the rat relevant to Parkinson's disease (1998) (7)
A Leukemia-Associated CD 34 / CD 123 / CD 25 / CD 99 þ Immunophenotype Identi fi es FLT 3-Mutated Clones in Acute Myeloid Leukemia (2015) (6)
Stem cells and neurological diseases. (2010) (6)
Dopamine denervation induces neurotensin immunoreactivity in GABA‐parvalbumin striatal neurons (2001) (6)
LONG-TERM CHANGES OF CORTICOSTRIATAL SYNAPTIC TRANSMISSION: POSSIBLE IMPLICATION FOR MOTOR MEMORY (1995) (6)
Met- and leu-enkephalins inhibit rat cortical neurons intracellularly recorded in vivo while morphine excites them: evidence for naloxone-sensitive and naloxone-insensitive effects (2004) (6)
Kyphoplasty: a new opportunity for rehabilitation of neurologic disabilities. (2004) (6)
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms (2005) (6)
Action of morphine on rat cortical neurons intracellularly recorded in vivo: Evidence for an excitatory postsynaptic effect which is naloxone insensitive (1986) (6)
D‐Tubocurarine reduces GABA responses in rat substantia nigra dopamine neurons (2003) (6)
Leukocyte aggregation: a possible link between infection and ischemic stroke. (1992) (6)
The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosus. (2008) (6)
CSF from MS patients can induce acute conduction block in the isolated optic nerve (2005) (6)
Sodium valproate and mental processes in newly referred epileptic patients. A computerized EEG study. (1995) (5)
Cerebral Whipple’s disease: clinical and cerebrospinal fluid findings (1998) (5)
Effects of Vitamin C on Fibroblasts from Sporadic Alzheimer’s Disease Patients (2008) (5)
Late-onset CMT2 associated with a novel missense mutation in the cytoplasmic domain of the MPZ gene (2010) (5)
Lack of association between Alzheimer's disease and the promoter region polymorphisms of the nicastrin gene (2004) (5)
Electrophysiologic Changes in Ventral Midbrain Dopaminergic Neurons Resulting from (+/−) -3,4-Methylenedioxymethamphetamine (MDMA—“Ecstasy”) (2007) (5)
Paraneoplastic cerebellar ataxia associated with anti-Hu antibodies and benign ganglioneuroma. (2014) (5)
MANGANESE DETECTED BY ELECTRON SPECTROSCOPY IMAGING AND ELECTRON ENERGY LOSS SPECTROSCOPY IN MITOCHONDRIA OF NORMAL RAT BRAIN CELLS (2002) (5)
Receptor and post-receptor mechanisms of ischemic long-term potentiation in the striatum. (2001) (5)
A novel mutation in the SPG3A gene (atlastin) in hereditary spastic paraplegia (2007) (5)
Inhibition of cathecol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neurons (1999) (5)
Physiological role of GABAb receptors in the mammalian neostriatum. (1992) (5)
Methamidophos transiently inhibits neuronal nicotinic receptors of rat substantia nigra dopaminergic neurons via open channel block (2004) (5)
Tranylcypromine, but not moclobemide, prolongs the inhibitory action of dopamine on midbrain dopaminergic neurons: An in vitro electrophysiological study (2000) (4)
Clinical and genetic studies in hereditary spastic paraplegia (2006) (4)
Advances in anatomy, embryology and cell biology. Vol. 111. Neurotransmission in hippocampus (1989) (4)
Plasma Concentrations of Neuroactive Steroids before and after Repetitive Transcranial Magnetic Stimulation in Depression (2003) (4)
N omega-nitro-L-arginine-methyl ester inhibits electrocortical recovery subsequent to transient global brain ischemia in Mongolian gerbil. (1992) (4)
Possible cellular mechanism accounting for the cell type-specific vulnerability in Huntington's disease. (2000) (4)
Morphine induces a spontaneous and evoked bursting activity in rat cortical neurons by adding a postsynaptic active mechanism to the synaptic input: An intracellular study In vivo (1988) (4)
On the spinal pathways mediating scalp‐SEPs to upper and lower limb nerve stimulation: case report and discussion (1986) (4)
Protective effect of clonazepam on ischemic brain damage induced by 10-minute bilateral carotid occlusion in Mongolian gerbils. (1993) (4)
Actions of Glycine on Non‐dopaminergic Neurons of the Rat Substantia Nigra (1995) (4)
Evidence in favour of GABA as an inhibitory transmitter in the rat striatum. (1981) (3)
Actions of Levodopa on rat substantia nigra zona compacta neurons (1992) (3)
Actions of the sodium channel inhibitor 202W92 on rat midbrain dopaminergic neurons (2003) (3)
Temperature sensitivity of dopaminergic neurons of the substantia nigra pars compacta: involvement of TRP channels (2005) (3)
Trace Amines Depress Gabab Response In Dopaminergic Neurons By Inhibiting Girk Channels (2005) (3)
Long-term changes of synaptic transmission: A topic of long-term interest (1996) (3)
Epileptic activity following cerebral ischemia in mongolian gerbils is depressed by CPP, a competitive antagonist of the N-methyl-d-aspartate receptor (1991) (3)
EEG changes induced by carbamazepine therapy at rest and during mental processes (1992) (3)
Preliminary evidence for an association between aggressive and hostile behaviour and 3 αα,, 5 αα -tetrahydroprogesterone plasma levels in schizophrenia (2004) (3)
Chapter 25 Oxidative Stress in Stroke Pathophysiology (2009) (3)
Cerebral reactivity in psychiatric and epileptic patients. (1969) (3)
[Anatomo-clinical study of the Steele-Richardson-Olszewski presenile syndrome (Description of a case)]. (1978) (2)
Role of D1 and D2 Dopamine Receptors in the Mammalian Striatum: Electrophysiological Studies and Functional Implications (1987) (2)
EVIDENCE FOR A NEUROMODULATORY ROLE OF DOPAMINE IN RAT STRIATAL NEURONS (1984) (2)
Basic research in substantia nigra and ventral tegmental area: clinical implications. (1995) (2)
The neuroprotective agent BW619C89 inhibits neuronal excitability and synaptic transmission in rat corticostriatal slices (1999) (2)
Dopamine: Cellular Actions (2009) (2)
Serial determinations of leukocyte aggregation in patients with ischemic stroke. (1993) (2)
Leukocyte aggregation in patients with chronic cerebrovascular disease (1994) (2)
P3-248: Association study of the APOA1 gene in an Italian population with Alzheimer's disease (2008) (2)
Prolactin response to bromocriptine in flunarizine-treated migrainous women. (1997) (2)
Rapidly progressive form of Creutzfeldt-Jakob disease without dementia: a case report. (1996) (2)
Glatiramer Acetate Reverses Plasticity and Cognitive Deficits Associated with Acute Inflammation in MS (P04.118) (2012) (2)
Persistent increase of leukocyte aggregation in a patient with relapsing ischemic stroke and ulcerative colitis (1995) (1)
Action mechanisms of gamma-aminobutyric acid (GABA) and glycine on rat cortical neurons. (1980) (1)
Manganese Toxicity: A Critical Reappraisal (2003) (1)
Changes of motor tract excitability to magnetic brain stimulation in spasticity (1990) (1)
Vulnerability of globus pallidus to Mn2+ may be dependent on preferential Mn2+ accumulation in pallidal neurons' nucleoli (2000) (1)
Searching modifier genes in the LHON 14484T > C mtDNA mutation associated with migraine-like disorder (2003) (1)
Effect of dopamine on the threshold of the voltage-dependent ionic channels in the rat brain. (1984) (1)
The midbrain slice preparation. An in vitro model to select potential anti-parkinsonian drugs? (2008) (1)
Basic Electrophysiology and Possible New Therapeutic Approaches to Movement Disorders (1994) (1)
[Treatment of choreic syndromes with sodium dipropylacetate]. (1977) (1)
Anti-GM1 activity and Plasmacell Dyscrasia (PCD) in neurological patients: Identical or indipendent phenomena? (1994) (1)
Localization of alpha-bungarotoxin binding sites within the rat corpus striatum. (1979) (1)
P3-020 Differential diagnosis amongst primary degenerative, mixed and vascular dementia: the contribution of the routine CSF title of Aβ 1–42, T-Tau and P-Tau181 (2004) (1)
Glutamate-triggered events inducing corticostriatal LTD (1999) (1)
Spontaneous Depolarizing Synaptic Potentials in the Neostriatum (1991) (1)
S-8-4 D2 dopamine receptors in the short- and long-term modulation of corticostriatal transmission (1996) (1)
The recovery cycle of the visual evoked potentials in normal subjects and in patients with endogenous depression. (1968) (1)
P3-262 Involvement of lysosomal system in Alzheimer’s diseases fibroblasts following vitamin C supplementation (2006) (0)
Excitability changes in sensorimotor brain areas and of long-latency EMG responses (1990) (0)
Basal ganglia disorders. An electrophysiologic approach. (1996) (0)
Agonists at group III mglurs modulate calcium currents in the adult rat neocortex (1996) (0)
Direct and synaptic effect of metabotropic glutamate receptors on striatal cholinergic interneurons excitability (2001) (0)
A2A receptors in mouse model of DYT1 primary dystonia (2021) (0)
cortical excitability and plasticity in humans Genetic variants of the NMDA receptor influence (2015) (0)
Valproate-induced changes in EEG background activity during mental processes in newly referred epileptic patients (1995) (0)
Impact of haemodialysis and renal transplant on multimodality evoked potentials (1985) (0)
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS (1993) (0)
Phosphodiesterase 10A and cyclic nucleotide catabolism in the physiopathology of experimental parkinsonism (2011) (0)
L-Type Ca 2 (cid:49) Channel Blockers Attenuate Electrical Changes and Ca 2 (cid:49) Rise Induced by Oxygen/Glucose Deprivation in Cortical Neurons (1998) (0)
Group I mGluRs enhance NMDA responses in the striatum (1996) (0)
P2-051 Cathepsin D, B and L are down-regulated in fibroblasts from Alzheimer’s disease patients (2006) (0)
Familial Dysautonomia (Riley-Day Syndrome) (2019) (0)
Abstracts of the 8th Meeting of the Italian Peripheral Nerve Study Group: 69 (2003) (0)
Comparison between anticholinergic and beta-2 agonist treatments by using pletismography and impulse oscillometry (2015) (0)
Non-clinical tests for the diagnosis of multiple sclerosis. (1987) (0)
Peripheral neuropathy in vasculitic and idiopathic hypereosinophilia: Differential features (1996) (0)
PARAPLEGIA SPASTICA EREDITARIA, EPILESSIA GENERALIZZATA IDIOPATICA IN DIVERSI MEMBRI DI UNA FAMIGLIA: UN NUOVO DISORDINE GENETICO (1992) (0)
Lamotrigine in severe epilepsy computerized EEG study and neuropsychological evaluation (1996) (0)
Multimodality evoked potentials in patients with chronic renal failure (CRF) (1985) (0)
FcJRIII discriminates between two subsets of VJ9VG2 effector cells with different responses and activation pathways Running title: helper and cytolytic effector memory in human γδ T cells (2004) (0)
the rat substantia nigra Protective role of hydrogen peroxide in oxygen-deprived dopaminergic neurones of (2007) (0)
["Recovery cycle" of visually evoked potentials in man]. (1966) (0)
Effect of carbamazepine treatment on EEG changes induced by different cortical activation patterns in newly referred epileptic patients. (1992) (0)
P4-115 Molecular analysis of the nicastrin promoter SNPS in Alzheimer's disease (2004) (0)
Motor evoked potentials to magnetic brain stimulation in amyotrophic lateral sclerosis (1995) (0)
[On the pathogenetic mechanisms of photo-sensitive epilepsy. (Apropos of the study of visual evoked responses in a case)]. (1968) (0)
D-aspartate exerts an opposing role upon age-dependent NMDAR-related synaptic plasticity and memory decay (2008) (0)
P3 components evoked by unilateral and bilateral somatosensory stimulation: normative data for the study of neglect syndrome. (1994) (0)
Neurochemistry of the emotions: behavioural and physiological correlates of catecholaminergic systems (1989) (0)
of extracellular ATP and immune suppression Treg cells: hydrolysis + Expression of ectonucleotidase CD39 by Foxp3 (2008) (0)
P4-186 Regulation of lysosomal enzymes expression in fibroblasts from Alzheimer's disease patients (2004) (0)
Alpha-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis. (2001) (0)
Plasma Allopregnanolone Levels in Menstrual Migraine Patients: A Possible Role in Migraine Susceptibility (2005) (0)
Short and Long Term Modulation of Synaptic Activity in Striatal Cholinergic Interneurons (2005) (0)
The excitatory action of morphine on rat cortical neurons is mediated by a post-synaptic mechanism. (1985) (0)
Detection of Aβ42 in the CSF of Alzheimer’s disease is influenced by handling temperature: indication of a reversible process of Aβ42 aggregation in vivo? (2010) (0)
Altered cortico-striatal plasticity and related behavioural parameters in reeler mice. European Journal of Neuroscience, Vol. 24, pp. 2061–2070, 2006 (2006) (0)
Expression of Acidic Glycohydrolases in Alzheimer’s disease fibroblasts (2001) (0)
[The use of sodium dipropylacetate in the treatment of parkinsonian tremor. Preliminary note]. (1977) (0)
expression and processing of cathepsin D in fibroblasts of patients with Alzheimer's Disease (2004) (0)
S-26-3 Evoked potentials monitoring in Parkinson's disease therapy (1995) (0)
[Agar electrophoresis of soluble proteins of the human brain extracted with diverse methods]. (1966) (0)
Loss of intracortical inhibitory mechanisms in a patient with cerebral tumor (1993) (0)
Changes in Ventral Midbrain opaminergic Neurons Resulting from / )-3 , 4-Methylenedioxymethamphetamine MDMA — “ Ecstasy ” ) (2007) (0)
different responses and activation pathways 2 effector cells with δ 9V γ RIII discriminates between two subsets of V γ Fc (2013) (0)
Computed Tomography in the Routine Evaluation of Headache (1994) (0)
Neurobiology of opioids: O.F.X. Almeida and T.S. Shippenberg (Springer, Berlin, 1991, 456 p., DM 228.00) (1993) (0)
P4-129 Genetic study of APH-1 and PEN-2, components of presenilin high molecular weight complex (2004) (0)
Metabotropic agonists reduce the excitatory transmission onto rat midbrain dopaminergic neurons in vitro (1996) (0)
Correction: Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington's Disease (2016) (0)
MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY. AUTHORS' REPLY (1997) (0)
Erratum to: α-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis (2014) (0)
Zinc distribution in various tissues, (brain, eye, skin, muscle and blood) of rat during hindlimb suspension. (1998) (0)
Trace Amines Cause More than One Effect on Dopaminergic Neurons (2005) (0)
Lateralization of EEG topographic mapping and spectral analysis: A statistical evaluation in focal epilepsy (1990) (0)
Motor evoked potentials in Strumpell-Lorraine disease: a family history (1995) (0)
P-13Non-muscle myosin II-C is abundantlyexpressed in skeletal muscle and associatedwith Z-lines (2011) (0)
A Leukemia-Associated CD 34 / CD 123 / CD 25 / CD 99-positive Immunophenotype Identifies FLT 3-mutated Clones in Acute Myeloid Leukemia (2015) (0)
Subject Index Vol. 33, 1993 (1993) (0)
Neurophysiology and neuropharmacology of the basal ganglia: experimental and clinical implications (1996) (0)
Cellular and molecular basis of synaptic transmission. NATO ASI series H: Cell biology (1989) (0)
ROLE OF Dl and D2 DOPAMINE RECEPTORS IN THE MAMMALIAN STRIATUM (1987) (0)
G.P.14.12 Myotonic dystrophy unlinked to DM1 and DM2 mutations in three siblings (2007) (0)
Spatacsin mutations in autosomal recessive juvenile ALS (2009) (0)
Repetitive trans-cranial magnetic stimulation: Effects on lower urinary tract function in multiple sclerosis patients (2005) (0)
P-13 Non-muscle myosin II-C is abundantly expressed in skeletal muscle and associated with Z-lines (2011) (0)
Low frequency of TAU mutations and further genetic heterogeneity in FTD (2002) (0)
Electrophysiological responses of basal ganglia neurons to O2 deprivation: an in vitro study (1996) (0)
Contents, Vol 33, 1993 / Publisher's Note (1993) (0)
α-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis (2001) (0)
The concept of "neuroprotection" in neurological diseases (2004) (0)
P-selectin glycoprotein ligand-1 selective increase of adhesiveness in brain venules : a critical role for T cells from patients with acute multiple sclerosis display + CD 8 (2003) (0)
Relations between the limbic system and the reticular meso-diencephalic formation at unitary level. (1967) (0)
Electromyographic study of the extrensic ocular muscles in a familial ocular myopathy. (1969) (0)
Subcellular localization of the myotonic dystrophy type 2 protein ZNF9 in skeletal muscle (2002) (0)
[Serum and liquor immunoelectrophoresis in normal subjects and in patients affected by degenerative and spondylosic myelopathies]. (1967) (0)
[Continuous partial epilepsy. Anatomo-clinical contribution]. (1969) (0)
Biochemical Markers of DBS-Induced Transition from “Off” to “On” State in Parkinsonian Patients (2005) (0)
[Immunoelectrophoresis of serum and cerebrospinal fluid with TEB buffer]. (1967) (0)
Oral Presentations (2003) (0)
Adult polyglucosan body disease (APBD) presenting with a bulbocerebellar syndrome (1997) (0)
Characterization of GABA and Glycine Actions on Substantia Nigra Zona Compacta Neurons (1991) (0)
Neurophysiological evidence of ipsilateral activation during motor recovery in patients with stroke: a study with motor evoked potentials (1995) (0)
Dbs in Parkinsonian Subthalamic Nucleus: Electrophysiological and Biochemical Changes (2002) (0)
[Relations between the limbic system and meso-diencephalic reticular formation studied at the unit level]. (1966) (0)
New Insights Into mGluRs Function in the Substantia Nigra Pars Compacta (2002) (0)
Apomorphine Responses in Globus Pallidus and Subthalamus of Parkinsonian Patients Undergoing Stereotaxic Neurosurgery: Lack of Evidence for the So-Called Indirect Pathway (2002) (0)
Effect of chronic treatment with Lamotrigine on nocturnal sleep and daytime somnolence (1996) (0)
Motor tract excitability changes in spastic patients: studies with non-invasive brain stimulation. (1990) (0)
MidbrainKinase in Dopamine Neurons of the Rat Group I mGluRs Coupled to G Proteins Are Regulated (2015) (0)
Ras differentially regulates lysosomal enzymes expression (2004) (0)
[Microiontophoretical application of GABA and L-glutamic-acid on neurons of the mammalian C.N.S (author's transl)]. (1974) (0)
Dopamine-Dependent Long-Term Potentiation Induced by 3-Nitropropionic Acid in Striatal Medium Spiny Neurons (2002) (0)
NADPH neurons in gerbils Nitric oxide inhibition aggravates ischemic damage of hippocampal but not of (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giorgio De Bernardi?

Giorgio De Bernardi is affiliated with the following schools:

Giorgio De Bernardi's Academic­Influence.com Rankings

Giorgio De Bernardi's Degrees

Why Is Giorgio De Bernardi Influential?

Giorgio De Bernardi's Published Works

Published Works

What Schools Are Affiliated With Giorgio De Bernardi?

Giorgio De Bernardi's AcademicInfluence.com Rankings